Growth Hormone Releasing Peptide 6 (GHRP6) reduces liver fibrosis in CCl4 chronically intoxicated rats

Tissue fibrosis is a leading cause of morbidity and mortality. Current treatments for conditions such as hepatic fibrosis have been unsuccessful. The growth hormone relasing peptide 6 (GHRP6) is endowed with cardioprotective actions but its antifibrotic effect had not been anticipated. We examined t...

Full description

Bibliographic Details
Main Authors: Jorge Berlanga-Acosta, Dania Vázquez-Blomquist, Danay Cibrián, Yssel Mendoza, María E Ochagavía, Jamilet Miranda, José Suárez, Yolanda González-Ferrer, José M Vila, Angel Abreu, Dayana Ugarte-Moreno, Yolanda Cruz, Ivon Howland, Rosa Coro-Antich, Olga S León, Ricardo Bringas, Diana García del Barco, Karelia Cosme-Díaz, Daniel Palenzuela, Julio R Fernández, Marcelo Nazabal, Isabel Guillén, Alberto Cintado, Lidia Inés, Ernesto López-Mola, Gerardo E Guillén-Nieto
Format: Article
Language:English
Published: Elfos Scientiae
Series:Biotecnología Aplicada
Subjects:
Online Access:http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1027-28522012000200002&lng=en&tlng=en